Serial 99027039
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99027039
- Mark type
- Design / logo
- Filed
- 03 Feb 2025
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Edward C. Meagher
Goods and services
- Class 044 — Medical, beauty and agricultural services: Molecular testing for infectious diseases involving the identification of pathogens and the detection of antibiotic resistance genes and analysis services in the prediction of the best antibiotic solution, for medical diagnostic or treatment purposes; medical, pathological and virus testing for medical diagnostic or treatment purposes; Antibody testing for medical diagnostic or treatment purposes; Genetic testing for medical diagnostic or treatment purposes; Urine testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; biological tissue testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Owner
- Promus Diagnostics, LLC, Southlake, TX, US
- Promus Diagnostics, LLC, Southlake, TX, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 30 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Jul 2025 — NON-FINAL ACTION E-MAILED
- 16 Jul 2025 — NON-FINAL ACTION WRITTEN